Free shipping | NZ registered doctors | 100% online

Afterpay available

Clinically-backed weight loss treatment

Mounjaro®

from $599p/m*

Mounjaro® is a once-a-week, prescription injection designed to support long-term weight management and health improvement.

Easy to take

Self-administered using a simple, pre-filled KwikPen. Most people use it at home with ease and confidence.


Reduces your appetite

Designed to help you feel fuller for longer, so you naturally eat less and feel more in control of your hunger.


Supports sustained weight loss

When paired with healthy lifestyle changes, Mounjaro® can help you lose weight and keep it off over time.


Mounjaro contains Tirzepatide

A dual GIP and GLP-1 receptor agonist. An approach to weight loss that targets two hormone receptors involved in appetite and metabolism.


Boosts overall health

May also help improve a range of health markers, including blood pressure, cholesterol levels and blood sugar¹


Mounjaro® (tirzepatide injection 2.5mg-15mg) is unfunded prescription medicine – payment for this medicine and any additional doctor and pharmacy fees will be required. Mounjaro is indicated in additional to diet and exercise for chronic weight management, including weight loss and weight maintenance, in adults who meet certain BMI criteria. Mounjaro® has risks and benefits. Use strictly as directed. If you experience side effects see your doctor, pharmacist or healthcare professional. Please refer to the Mounjaro® Consumer Medicine Information available at www.medsafe.govt.nz. Mounjaro is a registered trademark of Eli Lilly and Company (NZ) Limited, Auckland.

Setting the standard for telehealth

We meet the highest regulatory standards, giving you confidence when it matters most.

All care is provided by MCNZ-registered healthcare professionals. Your consult will be with a doctor registered with the Medical Council of New Zealand (MCNZ), ensuring safe and compliant care.

QIP Accreditation recognises our dedication to delivering high-quality and exceptional care.

Legitscript demonstrates our dedication to operating a secure and ethical telehealth service.

We're proudly ISO/IEC 27001 certified for our information security standards. We believe in setting the highest of standards on the systems that manage your health.

Achieve up to 22% body weight reduction with Mounjaro®¹

and you may also see improvements in the following:

In the trial¹, people using Mounjaro showed greater reductions in systolic blood pressure compared to those on placebo at 72 weeks.¹

Participants in the trial¹ also showed improvements in key cholesterol measures, including reductions in triglycerides and non-HDL cholesterol and increases in HDL (”good”) cholesterol, compared to placebo.

Participants in the trial¹ showed greater reductions in waist circumference, supporting improvements in overall cardiometabolic risk profile.¹

A further analysis of the same trial² found improvements in insulin sensitivity, even in people without diabetes.

See if you're eligible
Mounjaro New Zealand at Moshy

¹ Jastreboff et al., N Engl J Med. 2022;387:205–216 (SURMOUNT-1). Based on a 72-week clinical trial in adults with obesity (BMI ≥30) or overweight (BMI ≥27 with weight-related comorbidity), without type 2 diabetes, combined with a lower-calorie diet and increased physical activity. Participants using Mounjaro 15 mg lost an average of 22.5% of their body weight after 72 weeks. Results may vary. ² https://doi.org/10.2337/dc25-0763

Real results from clinical studies

In a medical trial, adults using Mounjaro achieved significant weight loss when combined with diet and exercise¹:

89%
of adults on Mounjaro 5 mg lost 5% or more of their body weight, compared with 28% taking placebo
96%
of adults on Mounjaro 10 mg and 15 mg lost 5% or more of their body weight, compared with 28% taking placebo
63%
of adults on Mounjaro 15 mg lost 20% or more of their body weight, compared with 1.3% taking placebo

These results were seen in adults with obesity or those who were overweight with weight-related health conditions, without type 2 diabetes. All participants followed a reduced-calorie diet and increased physical activity.

What to expect when taking Mounjaro

What your journey on weight loss medication may look like. Individual results may vary.

Getting started

Month 1

You'll ease in with a low dose (2.5 mg). This phase is about adjusting, not major weight loss just yet. Some mild side effects like nausea are common early on. Our care team will help you adjust.

Building momentum

Month 2-3

You might notice your appetite drop and some early weight changes. We'll keep track of your progress with monthly check-ins.

Seeing progress

Month 4-6

This is when many people start seeing real changes in weight reduction, energy and mood.

Long term balance

Beyond month 6

Results may continue or stabilise as part of your routine care. We'll support you on your maintenance journey.

FAQs

Explore our weight loss program

Get started on Mounjaro® today

Personalised care goes beyond medication. With unlimited support from medical professionals, exclusive private community access and more. Start your Mounjaro® journey today from $599 a month

Get started

*Subject to eligibility. Prices may vary across dosages. Your practitioner will assess if this is appropriate based on your medical history.